Palmitoylethanolamide in the Treatment of Chronic Pain Caused by Different Etiopathogenesis
Gatti A, Lazzari M, Gianfelice V, Di Paolo A, Sabato E, Sabato AF
Published in Pain Medicine
Methodology
Multicenter observational study of PEA added to standard analgesic therapy in patients with chronic pain of varied etiology
Key Findings
Pain intensity decreased significantly from baseline during PEA add-on therapy across neuropathic, mixed and nociceptive pain groups
Conclusions
Add-on PEA was associated with clinically meaningful reductions in pain intensity across pain etiologies
Limitations
Open-label design without placebo control limits causal inference
Supplements Studied
Pain intensity decreased significantly from baseline during PEA add-on therapy across neuropathic, mixed and nociceptive pain groups
Outcomes Measured
Pain intensity decreased significantly from baseline during PEA add-on therapy across neuropathic, mixed and nociceptive pain groups
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.